FDA Inspection 1018515 — David Butuk

David Butuk — FEI 3006021087

The FDA completed an inspection of David Butuk on June 23, 2017 in Meridian, ID. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 23, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Meridian, ID (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752621 CFR 312.62(a)Accountability records